Thermo Fisher Scientific vs Amgen: Fair Value & Quality
Both stocks run through our 21 valuation models. Here is how Thermo Fisher Scientific (TMO) and Amgen (AMGN) compare, as of Jul 23, 2026.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Thermo Fisher Scientific · Health Care
Amgen · Health Care
Bottom line
As of Jul 23, 2026, Fair Value Calculator sees Amgen as the more attractively valued of the two: Thermo Fisher Scientific trades at $523 versus a fair value of $308 (-41%), while Amgen trades at $366 versus $252 (-31%).
Amgen has the higher quality score (67/100).
See the full analysis →See the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models, not a recommendation and not financial advice. Values change with price and fundamentals; the date shown above applies.